John L. Magnani - 11 Nov 2022 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
SVP of Research, CSO
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
11 Nov 2022
Net transactions value
+$52,703
Form type
4
Filing time
14 Nov 2022, 15:11:48 UTC
Previous filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Purchase $52,703 +45,045 +14% $1.17 366,078 11 Nov 2022 Direct F1
holding GLYC Common Stock 4,845 11 Nov 2022 By GlycoTech Corporation F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.10 to $1.20 per share, with a weighted average purchase price of $1.17 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.